Iambic to Participate in April Investor Conferences
Iambic official newsroom · Indexed industry source record · Source published: Thu Apr 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Indexed here: Thu Oct 08 2026 09:09:13 GMT+0000 (Coordinated Universal Time)
Saved source excerpt
SAN DIEGO, CA – April 2, 2026 – Iambic , a clinical-stage life science and technology company developing novel medicines using its AI-driven drug discovery and development platform, today announced its participation in upcoming investor conferences: Needham Virtual Healthcare Conference: April 13-16 Bernstein’s Best of Biotech Symposium : April 15 Citi’s 4th Annual AI Summit : April 15-16 Tom Mill
This is a cited excerpt from the source. Read the original link for the complete text. Automated indexing and topic classification do not constitute fact verification.